| Title： | Management of drug-induced Acute Kidney Injury: a Comprehensive Guideline |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | Grading of Recommendations Assessment, Development, and Evaluation (GRADE) |
| Development unit： | Center for Drug Reevaluation, the National Medical Products Administration of China (NMPA) |
| Registration time: | 2020-10-21 |
| Registration number： | IPGRP-2020CN161 |
| Purpose of the guideline: |
Latest registration
